CING

Cingulate Inc. CING

CING
Cingulate Inc. ALLR
Allarity Therapeutics, Inc. LEXX
Lexaria Bioscience Corp. LIXT
Lixte Biotechnology Holdings, Inc. KAPA
Kairos Pharma, Ltd. SYBX
Synlogic, Inc. CASI
CASI Pharmaceuticals, Inc. CLSD
Clearside Biomedical, Inc. ENTO
Entero Therapeutics, Inc. NCNA
NuCana plc

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CING ALLR LEXX LIXT KAPA SYBX CASI CLSD ENTO NCNA
6M -1.70 % 6.06 % -35.93 % 419.90 % 17.62 % -2.50 % -41.08 % -92.06 % 89.21 % -81.13 %
YTD -20.78 % -5.41 % -75.65 % 82.43 % -51.49 % -17.61 % -74.30 % -93.02 % 35.57 % -98.65 %
1Y -16.18 % -2.78 % -76.37 % 104.55 % -55.56 % -17.02 % -75.05 % -92.83 % 39.15 % -98.74 %
3Y -98.13 % -100.00 % -76.27 % -17.35 % -71.45 % -89.38 % -48.24 % -93.99 % -98.74 % -99.91 %
5Y -99.62 % -100.00 % -87.50 % -88.33 % -71.45 % -96.42 % -97.38 % -96.86 % -100.00 % -99.99 %
10Y -99.62 % -100.00 % -87.50 % -77.50 % -71.45 % -97.19 % -92.10 % -99.08 % -100.00 % -100.00 %
From the beginning -99.62 % -100.00 % -87.50 % -99.85 % -71.45 % -64.22 % -99.96 % -99.08 % -100.00 % -100.00 %

Dividend